Trial intelligence / Profile preview

Integrative Medicine for Rapid Progressive Central Precocious Puberty

NCT03963752Phase 4Completed

Sponsor
Children's Hospital of Fudan University
Start
Aug 2019
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziyinxiehuo, megestrol in central precocious puberty (CPP), sponsored by Children's Hospital of Fudan University. Started Aug 2019; status: completed.

02

Drugs

ziyinxiehuomegestrol
03

Conditions

central precocious puberty (CPP)

Beyond the preview

Go deeper on NCT03963752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03963752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call